Teligent, Inc. Announces Adjournment of Special Meeting of Stockholders
November 25, 2020 12:00 ET
|
Teligent, Inc.
Scheduled to Reconvene on December 16, 2020Company Urgently Encourages Stockholders to Vote BUENA, N.J., Nov. 25, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT), a New Jersey-based...
Teligent, Inc. Announces Adjournment of Special Meeting of Stockholders
November 11, 2020 10:54 ET
|
Teligent, Inc.
Scheduled to Reconvene on November 25, 2020Company Urgently Encourages Stockholders to Vote BUENA, N.J., Nov. 11, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT), a New Jersey-based...
Teligent, Inc. Announces Adjournment of Special Meeting of Stockholders
October 22, 2020 11:25 ET
|
Teligent, Inc.
Scheduled to Reconvene on November 11, 2020Company Urgently Encourages Stockholders to Vote BUENA, N.J., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT), a New Jersey-based...
Teligent Announces Completion of Series D Convertible Note Exchange
September 23, 2020 08:50 ET
|
Teligent, Inc.
BUENA, N.J., Sept. 23, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, announced the closing of the...
Teligent, Inc. Announces Second Quarter 2020 Results
August 19, 2020 07:30 ET
|
Teligent, Inc.
BUENA, N.J., Aug. 19, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the second...
Teligent, Inc. to Hold Conference Call for Second Quarter 2020 Financial Results and Business Update on Wednesday August 19th, 2020
August 14, 2020 08:30 ET
|
Teligent, Inc.
BUENA, N.J., Aug. 14, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, announced they will hold a conference call at 8:00AM ET on...
Teligent Announces Completion of Series C Convertible Note Financing and Exchange
July 20, 2020 16:05 ET
|
Teligent, Inc.
BUENA, N.J., July 20, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, announced the closing of the...
Teligent, Inc. Announces the Appointment of John Celentano as Chairman of the Board
July 20, 2020 08:45 ET
|
Teligent, Inc.
BUENA, N.J., July 20, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT) (“Teligent” or the “Company”), a New Jersey based specialty generic pharmaceutical company, is pleased to announce that...
Teligent, Inc. Announces Hiring of Chief Legal Officer and Corporate Secretary
July 17, 2020 08:45 ET
|
Teligent, Inc.
BUENA, N.J., July 17, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT) (“Teligent” or the “Company”), a New Jersey based specialty generic pharmaceutical company, today announced the hiring of...
Teligent Regains Compliance with NASDAQ Listing Requirements
June 22, 2020 16:15 ET
|
Teligent, Inc.
BUENA, N.J., June 22, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, announced today that it...